Presentation is loading. Please wait.

Presentation is loading. Please wait.

Gregg VandeKieft, MD, MA Washington State Hospice and Palliative Care Annual Meeting Chelan, WA October 12, 2015.

Similar presentations


Presentation on theme: "Gregg VandeKieft, MD, MA Washington State Hospice and Palliative Care Annual Meeting Chelan, WA October 12, 2015."— Presentation transcript:

1 Gregg VandeKieft, MD, MA Washington State Hospice and Palliative Care Annual Meeting Chelan, WA October 12, 2015

2 Gregg VandeKieft, MD, MA System Lead Physician for Palliative Care, Providence Health and Services (PH&S), Renton, WA Regional Medical Director for Palliative Care, PH&S Southwest Washington Region, Olympia, WA Inpatient and Outpatient Palliative Care, Providence St. Peter Hospital, Olympia, WA Formerly Hospice Medical Director, Providence Sound Home Care and Hospice, Olympia, WA  gregg.vandekieft@providence.org  Twitter: @vandekieftg

3 Dr. VandeKieft has no commercial relationships or conflicts of interest to report.

4  At the conclusion of this presentation, participants will be able to: Define delirium and terminal agitation List common causes of terminal agitation Describe the initial assessment for delirium Recommend non-pharmacologic interventions and medication management for delirium and terminal agitation

5 Do not go gentle into that good night, Old age should burn and rave at close of day; Rage, rage against the dying of the light. Dylan Thomas, 1947

6  Delirium is a medical condition, rather than a psychiatric condition  If possible identify and treat the underlying cause; less practical in the actively dying  Underlying dementia increases risk of delirium 2-3x  Terminal agitation is very common, treatment is often non-pharmacological

7  A transient global disorder of cognition not a disease but a syndrome - multiple causes that produce a similar array of symptoms  A medical emergency 10-25% mortality in patients admitted with delirium up to 75% mortality in patients who develop delirium during hospitalization early diagnosis and treatment correlates to better outcomes

8  Clinical spectrum of unsettling behaviors and cognitive disturbance in the last hours to days of life Symptoms include: irritability, anxiety, distress, inattention, hallucinations, paranoia Signs include: restlessness, fidgeting, grimacing, moaning, attempts to get out of bed  Increased risk with certain medications Anticholinergics, opioids, benzodiazepines, steroids, antipsychotics, anticonvulsants

9  Disturbance in attention and awareness  Change in cognition not better accounted for by an established or evolving dementia.  Acute onset (hours to days) and fluctuates over the course of the day  History, exam, and/or labs indicate the disturbance is caused by a medical condition, intoxicating substance, medication, or more than one cause.

10  Estimated incidence in hospital 40% of hospitalized patients >65 yrs old  10-20% of elderly patients at time of admission 50% of patients after hip fracture 40% of patients in ICU 20% of patients on general medical ward  Advanced cancer patients 30-50% of on admission to hospital or hospice  80-90% of these patients experience delirium in their final hours to days of life  can be effectively treated in 30-75% of cases

11  Age >60  Men > women  Major medical illness or major surgery  Pre-existing brain pathology dementia, stroke, tumor  Psychiatric illness, including depression  Polypharmacy  Substance abuse

12 Clinical Features of Delirium  Acute onset – hours to days  Fluctuating levels of consciousness  Decreased ability to maintain attention  Emotional lability  Agitation or hypersomnolence  Altered cognitive function

13  Delirium acute onset, cognitive changes fluctuate alertness and attention wax and wane, speech confused and disorganized  Dementia gradual onset, chronic but stable memory deficits and executive function disturbance intact alertness and attention, but deficits in speech and thought processes

14 Characteristic Cognitive Deficits  Speech disturbance slurred, mumbling, incoherent, disorganized  Language impairments word finding difficulty  Memory dysfunction short-term memory impaired; disoriented to persons, place, time  Perceptual disturbance delusions, hallucinations, misrepresentations

15  76 year old woman with non-small cell lung cancer, metastatic to pelvis and spine s/p chemo and radiation, now on hospice no known psychiatric issues or dementia neighbors called police after she wandered into their house confused – she became combative with the police Paramedics bring her to ER for evaluation

16  Direct effects of cancer on CNS metastatic disease higher circulating cytokine levels  Indirect effects of cancer cancer related organ dysfunction - e.g., liver paraneoplastic syndromes infections, electrolyte disturbance  Exogenous factors chemotherapy, radiation therapy opioids, polypharmacy

17  Brain metastasis delirium not typically initial manifestation, but…  Medication reaction or interaction very common – review med list, timing of medications relative to onset of symptoms eliminate all meds that are not essential  Alcohol or drug withdrawal consider EtOH if onset 24-48 hrs after hospital admit has patient missed regular psychotropics or opioids?  Intracranial bleed consider unwitnessed fall, especially for debilitated or thrombocytopenic patients

18  Hyperactive delirium agitated, may be combative e.g., alcohol withdrawal  Hypoactive delirium hypersomnolent, unable to maintain attention when awake e.g., hepatic encephalopathy, hypercapnea  Mixed – has features of both fluctuations more pronounced daytime sedation, nocturnal agitation

19  Pitfalls in diagnosis Hyperactive: misinterpreted as primary psychiatric issue, medical workup is delayed Hypoactive: not a “problem patient” so delirium not recognized as quickly  Clinical diagnosis no single diagnostic test  Targeted workup based on differential diagnosis thorough history is essential  review chart for new symptoms and/or behavioral changes  review medication list, lab work, diagnostic imaging

20  Feature 1: Acute onset, fluctuating course  Feature 2: Inattention  Feature 3: Disorganized thinking  Feature 4: Altered level of consciousness  CAM + for delirium if 1 and 2 plus either 3 or 4

21

22 http://www.hospitalelderlifeprogram.org/delirium-instruments/

23

24  In ER Rose undergoes lab tests, receives IV fluids, electrolytes, meds, becomes marginally oriented a mental health professional is consulted, determines she is able to make her own health care decisions and cannot be hospitalized against her wishes – she refuses admission and is discharged home against medical advice the following day, her hospice nurse finds her covered with feces, rambling incoherently

25  Electrolyte disorders hypercalcemia, hyponatremia, hyperkalemia  Drug reactions, interactions, or toxicity benzodiazepenes, opioids, anticholinergics, steroids, digoxin, Parkinsons meds, H2-blockers, alcohol  Infection  Hypoxemia  Hyper- or hypoglycemia  Hypotension  Hepatic or renal encephalopathy  Most cases are multifactorial

26  Biochemical abnormalities as organs fail Hypercalcemia especially common in cancer  Opioid or other drug toxicity  Drug interactions  Pain  Fever, with or without infection  Spiritual or existential distress  Unresolved psychosocial issues

27

28  Interview patient when possible delirium covers a wide range of presentations, some patients can provide significant history  If possible, talk to family or caregivers who know patient’s baseline Review records carefully  Typical tests of cognitive function (e.g., MMSE) not very helpful in delirium use tests that measure attention – e.g., serial 7s, spell world backward, or list months in reverse

29  For all studies, ask: Will it alter treatment? how does test fit within broader context of illness trajectory and treatment goals?  Brain mets: cranial CT or MRI  Infection: CBC, UA, cultures, x-rays  Electrolyte abnormalities: chem panel  Liver failure: hepatic panel, ammonia  Renal failure: BUN/Cr, monitor I/Os  Respiratory failure: O2 sat, ABGs

30  Rose is brought back to ER, remains disoriented, admitted Hospice GIP status work-up showed UTI, possible pneumonia – started on IV antibiotics required 1:1 sitter due to behavioral outbursts responded well to p.r.n. haloperidol … but no SNF would take her while she needed 1:1 or was receiving haloperidol risperidone added, good response, transferred to SNF, did well until she died 6 weeks later

31  Identify and treat underlying cause, if able Often not practical during actively dying phase When etiology uncertain, treat symptoms  Environmental therapy Facilitate a quiet, peaceful setting Provide cues: family photos, calendar, clock  Address psychosocial issues, spiritual or existential concerns Involve family, staff, spiritual care, music thanatology

32  “Pharmacologic debridement” Review med profile, look for potential offending agents, eliminate all unnecessary meds  Pharmacotherapy if non-pharmacologic interventions unsuccessful Target patients who are severely agitated  Behavior interferes with essential interventions or poses a safety hazard to self, family, staff Avoid restraints! Usually worsens agitation

33  Benzodiazepenes generally avoid - can paradoxically worsen symptoms helpful for alcohol withdrawal, anxiety  Conventional antipsychotics haloperidol 1 st line in hospital or home, but usually not an option in nursing homes IV or oral – onset of action 5-20 min for IV route  Atypical antipsychotics helpful for “maintenance” use, especially olanzapine or risperidone

34 Key Points  Delirium is a medical condition, rather than a psychiatric condition  If possible identify and treat the underlying cause; less practical in the actively dying  Underlying dementia increases risk of delirium 2-3x  Terminal agitation is very common, treatment is often non-pharmacological

35


Download ppt "Gregg VandeKieft, MD, MA Washington State Hospice and Palliative Care Annual Meeting Chelan, WA October 12, 2015."

Similar presentations


Ads by Google